Patterns of relative INSTI susceptibility for 1,536 viruses in HIVDB with 209 distinct INSTI-Resistance patterns*.

Reporting (n = studies apart from final column).

Non-Pharmacological Intervention.

Summary results of severity assessment by expert panel.

Diagnosis of expert panel and Xpert results of smear negative presumptive TB patients in TB DOTS facility, Dasmariñas and Trece Martirez City, 2017.

Pre-determined criterion questions used by the expert panel as recommended by CHNRI.

Bone Mineral Density Assessment.

Geographic, clinical, and microbiological characteristics of mother–infant pairs.

Geographic, clinical, and microbiological characteristics of people with GBS.

In vitro susceptibilities associated with the 14 INSTI drug resistance mutation patterns.

Role prioritisation of pharmacists’ roles for the disaster PPRR phases obtained in round 1 of the Delphi study by the expert panel.

Comparison of diagnosis of expert panel vs a single physician diagnosis of presumptive smear negative patients among smear negative presumptive TB patients in TB DOTS facility,...

Patterns of predicted relative NRTI susceptibility profiles for 35,377 viruses in HIVDB with 4,749 Distinct NRTI-Resistance patterns*.

Themes and corresponding modules of Titukulane.

Final Consensus on 21 roles pharmacists are capable of undertaking in the response phase of a disaster.

Clinical relevance.

Final Consensus on eight roles pharmacists are capable of undertaking in the recovery phase of a disaster.

Summary of reviewers’ assessments of evidence about Zika virus infection and congenital abnormalities, by causality dimension.

Pharmacological Intervention.

Modules as prioritized during the expert panel excise.